This month we’re focusing on techniques and emerging approaches – take a look at our infographic below to learn more about the use of cerebral organoids in research.
This week’s industry news round-up reveals the latest updates around spinal muscular atrophy, Parkinson’s disease and acute stroke.
To mark World Multiple Sclerosis Day, we’re taking the opportunity to look back on some of the highlights in the field so far this year.
Alzheimer’s Society has worked with an expert taskforce to develop goals and detailed recommendations for research into dementia prevention, diagnosis, intervention and care by 2025.
This week, our industry report covers neuroblastoma, DUB inhibitors for neurodegenerative diseases and pediatric multiple sclerosis.
This International Nurses Day, we spoke to a series of neuroscience nurses on what inspired them to become a nurse and any advice they have for students.
In this week’s industry news round-up we set the focus on Alzheimer’s disease (AD), with another clinical trial termination announced and a new framework for defining AD.
In this week’s round-up, we cover the latest industry news from depression and Parkinson’s disease. Find out more about our selection of the highlights this week.
As more Alzheimer’s research programs are terminated, check out our highlights from the latest neuroscience and neurology industry headlines.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.